throbber
Trials@uspto.gov
`571-272-7822
`
`Paper 49
`Date: June 14, 2022
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`LIQUIDIA TECHNOLOGIES, INC.,
`Petitioner,
`v.
`UNITED THERAPEUTICS CORPORATION,
`Patent Owner.
`
`IPR2020-00770
`Patent 9,604,901 B2
`
`
`
`
`
`
`
`
`
`Before ERICA A. FRANKLIN, ZHENYU YANG, and
`JOHN E. SCHNEIDER, Administrative Patent Judges.
`
`PER CURIAM
`
`Denying Patent Owner’s Request for Rehearing of
`Final Written Decision
`37 C.F.R. § 42.71(d)
`
`
`
`
`
`
`
`

`

`IPR2020-00770
`Patent 9,604,901 B2
`
`
`INTRODUCTION
`Liquidia Technologies, Inc. (“Petitioner”) filed a Petition (Paper 1),
`seeking inter partes review of claims 1–9 of U.S. Patent No. 9,604,901 B2.
`We instituted trial to review the challenged claims. Paper 7. Thereafter,
`United Therapeutics Corporation (“Patent Owner”) filed a Response to the
`Petition (Paper 12), Petitioner filed a Reply (Paper 15), and Patent Owner
`filed a Sur-reply (Paper 25).
`At the conclusion of the trial, we issued a Final Written Decision,
`determining that Petitioner has shown the unpatentability of claims 1–5, 8,
`and 9, but not claims 6 and 7. Paper 45 (“Decision” or “Dec.”). Patent
`Owner timely filed a Request for Rehearing of the Decision as to
`claims 1–5, 8, and 9. Paper 46 (“Reh’g Req.”). Patent Owner also timely
`filed a request for Precedential Opinion Panel (POP) review. Paper 47;
`Ex. 3002. The POP panel denied that request and instructed this panel to
`consider Patent Owner’s rehearing request. Paper 48, 2.
`For the reasons explained below, we deny Patent Owner’s Request for
`Rehearing.
`
`STANDARD OF REVIEW
`The party challenging a decision in a request for rehearing bears the
`burden of showing the decision should be modified. 37 C.F.R. § 42.71(d).
`A request for rehearing “must specifically identify all matters the party
`believes the Board misapprehended or overlooked, and the place where each
`matter was previously addressed.” Id.
`ANALYSIS
`Patent Owner argues that our Decision “relied on inadmissible,
`unsworn expert statements submitted by Petitioner that, when timely
`
`2
`
`

`

`IPR2020-00770
`Patent 9,604,901 B2
`
`objected to by Patent Owner, Petitioner failed to timely cure as required by
`[3]7 C.F.R. § 42.64(b)(2).” Reh’g Req. 2. The unsworn expert statements
`Patent Owner refers to are from Exhibit 1002, the purported Winkler
`Declaration. Id. at 4.
`During trial, the parties briefed, among other issues, whether we
`should exclude Exhibit 1002. Papers 31, 32, 37. In our Decision, we denied
`Patent Owner’s Motion to Exclude Exhibit 1002. See Dec. 54–58. And in
`determining that claims 1–5, 8, and 9 are unpatentable, we relied on certain
`statements from Exhibit 1002. Id. at 32–34, 36, 37, 41, 42 (citing Ex. 1002
`¶¶ 47, 49, 148, 151, 152, 159, 174, 176–178).
`In its Request for Rehearing, Patent Owner contends that we “erred by
`considering and relying extensively on the inadmissible original Winkler
`Declaration.” Reh’g Req. 6. Patent Owner, however, does not identify any
`matter that we allegedly misapprehended or overlooked. Indeed, in our
`Decision, we dedicated numerous pages discussing Patent Owner’s
`contentions regarding Exhibit 1002. See Dec. 54–58 (citing 37 C.F.R.
`§§ 42.2, 42.53, 42.63, 42.64).1 For example, we acknowledged that “[a]s
`Patent Owner correctly points out, Exhibit 1002, the purported declaration of
`Dr. Winkler, ‘does not state that the testimony is true or believed to be true,
`much less reference the penalty for making willful false statements.’” Id.
`at 54. We also agreed with Patent Owner that it timely objected to
`Exhibit 1002, which sufficiently put Petitioner on notice, but Petitioner
`failed to submit supplemental evidence in response by the required deadline.
`Id. at 55–57. Nevertheless, we found that Patent Owner suffered no undue
`
`
`1 Our regulations allow us to waive or suspend a requirement of part 42 of
`our Rules. See 37 CFR § 42.5(b).
`
`3
`
`

`

`IPR2020-00770
`Patent 9,604,901 B2
`
`prejudice, and thus, denied Patent Owner’s Motion to Exclude Exhibit 1002.
`Id. at 58.
`In its Request for Rehearing, Patent Owner argues that “[t]he Board
`does not have discretion to allow unsworn statements that fail to comply
`with the statutory sworn-testimony requirements, and it cannot rely on such
`statements over a timely, uncured objection just by asserting a lack of
`‘prejudice.’” Reh’g Req. 7. According to Patent Owner, the prejudice
`suffered is that “the Board actually relied on the challenged document.” Id.
`at 8. Patent Owner, however, does not point to where this alleged prejudice
`was previously addressed. See 37 C.F.R. § 42.71(d).
`Instead, in our Decision, we explained why Patent Owner suffered no
`undue prejudice. Dec. 58. Specifically, we pointed out that Patent Owner
`deposed Dr. Winkler, under oath, on his opinions in Exhibit 1002. Id.; see
`also Paper 44, 63:12–15 (“JUDGE SCHNEIDER: Doesn’t the fact that you
`were able to depose Petitioner's expert cure any issues that you might have
`had with the lack of authentication? MR. CARSTEN: Well, Your Honor,
`certainly we were able to depose him.”). Indeed, the record shows that,
`during trial, Patent Owner acknowledged that it did not suffer a specific
`cognizable prejudice. Dec. 58 (citing Paper 44, 64:5–6).
`Patent Owner does not identify where we misapprehended or
`overlooked its arguments as to Exhibit 1002. Rather, Patent Owner disagrees
`with our decision to deny its Motion to Exclude Exhibit 1002. It is not an
`abuse of discretion to have made an analysis or reached a conclusion with
`which a party disagrees. Thus, Patent Owner’s Request for Rehearing is
`denied.
`
`4
`
`

`

`IPR2020-00770
`Patent 9,604,901 B2
`
`
`ORDER
`
`Accordingly, it is
`ORDERED that Patent Owner’s Request for Rehearing is denied.
`
`
`
`FOR PETITIONER:
`Ivor R. Elrifi
`Erik B. Milch
`Cooley LLP
`ielrifi@cooley.com
`emilch@cooley.com
`
`FOR PATENT OWNER:
`Stephen B. Maebius
`George Quillin
`Daniel R. Shelton
`Foley & Lardner LLP
`smaebius@foley.com
`gquillin@foley.com
`dshelton@foley.com
`
`Shaun R. Snader
`United Therapeutics Corp.
`ssnader@unither.com
`
`Douglas Carsten
`Richard Torczon
`Wilson, Sonsini, Goodrich & Rosati
`dcarsten@wsgr.com
`rtorczon@wsgr.com
`
`
`
`5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket